Raphael Pharmaceutical (RAPH) Return on Assets (2021 - 2025)
Raphael Pharmaceutical (RAPH) posted Return on Assets of 1.04% for Q3 2025, down 185.32% sequentially from 0.37% in Q2 2025, and down 79.0% YoY from 4.97% in Q3 2024.
Raphael Pharmaceutical (RAPH) Return on Assets (2021 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Return on Assets for 5 years, with the latest figure at 1.04% in Q3 2025.
- Quarterly Return on Assets fell 79.0% year-over-year to 1.04% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 1.04% (down 79.0% YoY) and the FY2025 annual result came in at 0.81%, down 58.0% from the prior year.
- Return on Assets fell to 1.04% in Q3 2025 per RAPH's latest filing, from 0.37% in the prior quarter.
- Over five years, Return on Assets peaked at 0.08% in Q4 2023 and troughed at 1.04% in Q3 2025.
- A 5-year average of 0.28% and a median of 0.17% in 2022 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2024 and 2025: Return on Assets grew 18 bps in 2024, then sank 79 bps in 2025.
- Over 5 years, Return on Assets stood at 0.12% in 2021, then slumped by 50 bps to 0.18% in 2022, then soared by 56 bps to 0.08% in 2023, then tumbled by 887 bps to 0.78% in 2024, then sank by 34 bps to 1.04% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 1.04%, 0.37%, and 0.42% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 0.00% |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | -0.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.04% |
| Jun 30, 2025 | -0.37% |
| Mar 31, 2025 | -0.42% |
| Dec 31, 2024 | -0.78% |
| Sep 30, 2024 | -0.25% |
| Jun 30, 2024 | -0.11% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | -0.08% |
| Sep 30, 2023 | -0.12% |
| Jun 30, 2023 | -0.29% |
| Mar 31, 2023 | -0.17% |
| Dec 31, 2022 | -0.18% |
| Sep 30, 2022 | -0.25% |
| Jun 30, 2022 | -0.16% |
| Mar 31, 2022 | -0.09% |
| Dec 31, 2021 | -0.12% |